Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
Disaster Medicine and Public Health Preparedness|March 25, 2021
Risk and the Republican National Convention: Application of the Novel COVID-19 Operational Risk AssessmentDavid Callaway, Jeff Runge, Lucia Mullen, et al.Frontiers in Public Health|April 24, 2026
Effectiveness of public health measures and strategies to reduce risk of spread of respiratory pathogens at sporting mass gatherings: systematic literature reviewLucia Mullen, Amanda Kobokovich Mui, Crystal Watson, et al.Journal of Science and Medicine in Sport|February 5, 2026
Understanding the development and analyzing the implementation of the Tokyo 2020 and Beijing 2022 Playbooks to mitigate COVID-19 spread: recommendations for future GamesLucia Mullen, Amanda Kobokovich Mui, Vanessa Grégoire, et al.Neuropsychiatric Disease and Treatment|June 3, 2017
Characteristics, burden of illness, and physical functioning of patients with relapsing-remitting and secondary progressive multiple sclerosis: a cross-sectional US surveyHillary J Gross, Crystal WatsonClinicoeconomics and Outcomes Research : CEOR|November 23, 2018
Multiple sclerosis patients who are stable on interferon therapy show better outcomes when staying on same therapy than patients who switch to another interferonChao Chen, Ning Wu, Crystal WatsonHealth Security|June 28, 2017
Federal Funding for Health Security in FY2018Crystal Watson, Matthew Watson, Tara Kirk SellClinicoeconomics and Outcomes Research : CEOR|March 12, 2016
Short- and longer-term health-care resource utilization and costs associated with acute ischemic strokeBarbara H Johnson, Machaon M Bonafede, Crystal WatsonJournal of Drug Assessment|June 13, 2022
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimenCrystal Watson, Hemanth Gadikota, Arie Barlev, et al.CNS Drugs|June 27, 2015
Platform Therapy Compared with Natalizumab for Multiple Sclerosis: Relapse Rates and Time to Relapse Among Propensity Score-Matched US PatientsBarbara H Johnson, Machaon M Bonafede, Crystal WatsonClinicoeconomics and Outcomes Research : CEOR|January 1, 2014
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the USMachaon M Bonafede, Barbara H Johnson, Crystal WatsonPageof 7